May 13, 2026 / NTS GMT
Presentation
May 13, 2026 / NTS GMT
=====================
Corporate Participants
=====================
* Toru Kimura
Sumitomo Pharma Co Ltd - President, Representative Director
* Megumi Maruyama
Sumitomo Pharma Co Ltd - Vice President, Head - Corporate Communications
* Tsutomu Nakagawa
Sumitomo Pharma Co Ltd - Managing Executive Officer, Director
* Motoyuki Sakai
Sumitomo Pharma Co Ltd - Executive Vice President, Representative Director
* Yumi Sato
Sumitomo Pharma Co Ltd - Managing Executive Officer, Chief Director of R&D
=====================
Conference Call Participants
=====================
* Stephen Barker
Jefferies LLC - Analyst
* Hidemaru Yamaguchi
Citi Infrastructure Investments LLC - Analyst
* Seiji Wakao
JPMorgan Chase & Co - Analyst
* Hiroshi Wada
SMBC Nikko Securities Inc - Analyst
* Jaeheon Lee
Morgan Stanley & Co Ltd - Analyst
* Kazuaki Hashiguchi
Daiwa Securities Group Inc - Analyst
Sumitomo Pharma Co Ltd
(OTCPK:DNPUF)
$
8.4
(0%)
Market Cap: 3.52 Bil
Enterprise Value: 4.54 Bil
PE Ratio: 4.78
PB Ratio: 1.74
GF Score: 65/100 Full Year 2026 Sumitomo Pharma Co Ltd Earnings Presentation Transcript
May 13, 2026 / NTS GMT
Release Date Price:
$10.5
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot